AKBA
USDAkebia Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$2.100
Максимум
$2.145
Минимум
$2.070
Объем
4.47M
Фундаментальные показатели компании
Рыночная капитализация
563.4M
Отрасль
Drug Manufacturers - Specialty & Generic
Страна
United States
Статистические данные торговли
Средний объем
4.04M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Akebia Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
Связанные акции
AFBI
Affinity Bancshares Inc. (MD)
AGNCO
AGNC Investment Corp. Depositary Shares each representing a 1/1000th interest in a share of 6.50% Series E Fixed-to-Floating Cumulative Redeemable Preferred Stock
FUN
Six Flags Entertainment Corporation New
VSTO
Vista Outdoor Inc.
EQS
Equus Total Return Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.